Neoprobe signs Ethicon for distribution in US
This article was originally published in Clinica
Johnson & Johnson subsidiary Ethicon Endo-Surgery is to market Neoprobe's 1500 portable radioisotope detector in the US. The agreement, initially for one year, also covers the system's 14mm and 19mm reusable probes for gamma-guided lymphatic mapping and minimally-invasive surgery. The companies plan to extend the distribution agreement to cover Europe, Japan and Australia. Neoprobe is based in Dublin, Ohio.